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Abstract
Background: Cells adapt to various chronic toxic exposures in a multitude of ways to minimize further damage
and maximize their growth potential. Expression of L1 elements in the human genome can be greatly deleterious
to cells, generating numerous double strand breaks (DSBs). Cells have been reported to respond to chronic DSBs
by altering the repair of these breaks, including increasing the rate of homology independent DSB repair.
Retrotransposition is strongly affected by proteins involved in DSB repair. Therefore, L1 expression has the potential
to be a source of chronic DSBs and thus bring about the changes in cellular environment that could ultimately
restrict its own retrotransposition.
Results: We demonstrate that constitutive L1 expression leads to quicker DSB repair and decreases in the
retrotransposition potential of L1 and other retrotransposons dependent on L1 expression for their mobility. This
cellular adaptation results in reduced sensitivity to L1 induced toxicity. These effects can be induced by constitutive
expression of the functional L1 ORF2 alone, but not by the constitutive expression of an L1 open reading frame 2
with mutations to its endonuclease and reverse transcriptase domains. This adaptation correlates with the relative
activity of the L1 introduced into the cells.
Conclusions: The increased number of DSBs resulting from constitutive expression of L1 results in a more rapid
rate of repair. The cellular response to this L1 expression also results in attenuation of retrotransposition and
reduced sensitivity of the cells to negative consequences of L1 ORF2 expression. The influence does not appear to
be through RNA interference. We believe that the increased rate of DSB repair is the most likely cause of the
attenuation of retrotransposition. These alterations act as a fail safe mechanism that allows cells to escape the
toxicity associated with the unchecked L1 expression. This gives cells that overexpress L1, such as tumor cells, the
ability to survive the high levels of expression. However, the increased rate of break repair may come at the cost of
accuracy of repair of the lesion, resulting in increased genomic instability.
Background
Mammalian cells often evolve adaptive responses to deal
with chronic exposure to various toxic agents, including
ethanol and opiates [1-4]. Cells also adapt to chronic
exposure to sublethal doses of DNA double strand
breaks (DSBs) through the selection of cells with altered
DSB repair [1]. Typically, mammalian cells depend on a
balance between two broad classes of DSB repair to
ensure proper genome maintenance. Homologous repair
(HR) is a process largely dependent on homology,
whereas non-homologous end joining (NHEJ) is mostly
independent of homology [5]. Chronic sublethal levels
of DSBs cause an altered balance between these two
pathways, shifting the balance towards NHEJ [1].
Long interspersed element-1 (LINE-1 or L1) is the
most numerous and only currently active family of
human autonomous, non-long terminal repeat (LTR) ret-
rotransposons. They constitute 17% of the genome, with
approximately 500,000 copies. Most of these L1 elements
do not contain functional copies of the two open reading
frames (ORF1 and ORF2) required for efficient retrotran-
sposition [6-8]. Only around 100 L1 elements contain
functional copies of both ORFs, which may allow them to
contribute to DNA damage and human disease [7,9].
The L1 ORF2p has been demonstrated to contain
both endonuclease and reverse transcriptase activities,
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ORF2 domains play essential roles in target primed
reverse transcription (TPRT), the proposed mechanism
for the retrotransposition of L1 elements [13-15]. This
mechanism predicts the transient creation of a DSB at
the site of integration.
L1 expression is associated with DSB formation
[16,17], and long term exposure to sublethal levels of
DSBs has been associated with alterations in the repair
of DNA lesions [1]. Therefore, long term exposure to
L1 expression may also alter the response of a cell to
DNA damage, which may influence the retrotransposi-
tion process. Retrotransposition is strongly affected by
several DNA repair proteins, including excision repair
cross complementing/xeroderma pigmentosum F
(ERCC1/XPF), ataxia telangiectasia mutated (ATM) and
p53 [16,18]. Furthermore, the DSBs caused by L1 have
been implicated as a causative agent in creating chromo-
somal translocations normally associated with cancer
[19], probably through a NHEJ mechanism.
High levels of endogenous full length L1 mRNA
expression have been detected in multiple tissues and
cell lines [20]. The endogenous expression of this full
length L1 mRNA implies that various tissues and cell
lines are exposed to chronic expression of L1 ORF2p.
The expression of L1, particularly the L1 ORF2p, has
been shown to result in substantially decreased cellular
proliferation and increased cell death [17,21]. This toxi-
city is probably due to induction of DSBs associated
with the expression of L1 ORF2p, because a mutation in
the endonuclease domain of the L1 ORF2p greatly
diminishes the L1-associated toxicity.
Using cells stably expressing both functional and non-
functional L1 ORF2p, we show that cells adapt to the
constitutive expression of the functional L1 ORF2p in a
dose dependent manner, by repressing the retrotranspo-
sition of both L1 and Alu. Furthermore, this cellular
adaptation, which limits retrotransposition, also
diminishes the toxicity typically associated with the
expression of L1 ORF2p. We demonstrate that cells
exposed to constitutive L1 ORF2p expression have
altered DNA DSB repair kinetics, which provides a
potential explanation for the reduction of L1 and Alu
mobilization, and the diminished toxicity associated
with L1 expression.
Results
Constitutive L1 expression results in reduced
retrotransposition
Endogenous L1 mRNA is subject to splicing and prema-
ture polyadenylation [20,22,23], which results in a signif-
icant portion of the transcripts being truncated and
therefore not fully functional. Northern blots of several
common cancer cell lines (HCT116, HeLa and MCF7)
showed that all had L1 expression but variable levels of
processing, suggesting that endogenous expression of
active L1 elements varies greatly between these cell lines
( F i g u r e1 A ) .U s i n gas t a n d a r d retrotransposition assay
[12], we found an inverse correlation between the
observed endogenous full length (fl)-L1 mRNA levels
and L1 retrotransposition potential in these cell lines
(Figure 1B).
The inverse correlation between endogenous fl-L1
mRNA levels and the retrotransposition of a tagged L1
suggested the possibility that cells can adapt to constitu-
tive L1 expression by repressing retrotransposition. It is
also possible that the varied retrotransposition rates
could be caused by other cellular differences that made
the cell lines differentially tolerant to the expression of
L1 elements. To test the first possibility, we wished to
observe the effect of L1 expression on retrotransposition
in an isogenic background. We generated pools of cells
that stably expressed either the entire L1 element or
o n l yt h eL 1O R F 2r e g i o n .A sn e g a t i v ec o n t r o l s ,w e
established cells stably expressing either the L1 ORF2p
with inactivating mutations in both its endonuclease
and reverse transcriptase domains (L1 ORF2 ER–)o r
luciferase (Figure 2). Because L1 ORF2 expression gen-
erates DSBs [16], we confirmed its expression by investi-
gating DSB levels via the formation of p53 binding
protein (53BP)1 foci, a well established indicator of DSB
formation [24,25]. As expected, cells stably expressing
wild type L1 ORF2 showed significantly (P ≤ 0.05) ele-
vated levels of 53 BP1 foci compared with controls (see
Additional file 1), affirming the influence of L1 ORF2
expression in these cells. We further confirmed that
ORF2p was overexpressed several fold in our transfected
cell lines using a western blot to ORF2p (Additional
Figure 1C).
To test the effect of constitutive L1 expression on ret-
rotransposition, we measured the retrotransposition of
tagged L1 [12] and Alu [26] elements. Alu and L1 retro-
transposition in both HCT116 and HeLa cells stably
expressing L1 ORF2 (HeLa ORF2, HCT116 ORF2) were
significantly (P ≤ 0.05) lower than in corresponding con-
trol cells (HeLa ORF2 ER–, HCT luciferase) (Figure 2).
The magnitude of repression of retrotransposition was
generally greater for Alu elements than for L1 elements.
Because the ORF2p level in the stable cell lines is
expected to be relatively low compared with transient
transfection assays and also should be variable between
the various groups of cells, we cotransfected the cells
with either ORF2 or full length L1 to provide relatively
similar levels of ORF2 in the various cell lines to drive
the retrotransposition of the tagged Alu element. The
difference in the decrease in Alu retrotransposition was
unaltered when Alu retrotransposition was driven by
either a full length L1 or an L1 ORF2 (see Additional
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cells stably expressing either a full length L1 element or
the L1 ORF2 (Figure 2).
To determine whether increased L1 expression would
result in a more pronounced phenotype, we generated
HeLa cells that stably express a synthetic version of L1
that had been codon optimized to increase expression of
the element (HeLa Optimized L1) (See Wallace et al.
[21] for further description). When Alu and L1 retro-
transposition in these cells was measured, both Alu and
L1 retrotransposition were almost completely sup-
pressed (Figure 2).
Figure 1 Inverse correlation between endogenous full length L1 mRNA and retrotransposition potential. (A) Northern blot of
endogenous L1 mRNA (see text for method). FL1 or full length L1 mRNA, as determined by size is denoted by an arrow. L1 mRNA species
previously characterized as truncated products caused by internal splicing or premature polyadenylation are indicated by a bracket [22,23]. As a
loading control, the same blot was probed for b-actin RNA. (B) Inverse correlation between endogenous L1 mRNA Levels and retrotransposition
potential. Mobilization of a tagged L1, which confers neomycin resistance to a cell upon successful retrotransposition, as described previously,
[12] and the relative amount of endogenous full length L1 mRNA was measured in triplicate for HCT116, HeLa and MCF7 cells, and the means
and standard deviations plotted.
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to toxicity associated with transient L1 expression
We considered the possibility that the constitutive
expression of L1 ORF2 could have caused the HeLa
ORF2 cells to grow at an altered rate or otherwise be less
fit than HeLa ORF2 ER– cells, resulting in decreased ret-
rotransposition. To test this possibility, we measured the
growth rates of HeLa ORF2 and HeLa ORF2 ER – cells,
and found that their rates of growth were not signifi-
cantly different from one another (Figure 3A).
The transient expression of L1, and particularly L1
ORF2, is very toxic, resulting in the reduction of cellular
proliferation, and induction of apoptosis and cellular
senescence [16,17,21]. It is possible that HeLa ORF2
cells had a higher sensitivity to transient expression of
L1 ORF2, which could explain the reduced retrotranspo-
sition in these cells. To explore this possibility, we
measured the toxicity associated with transient L1
expression using a previously described colony forma-
tion assay [16]. Expression of either L1 or L1 ORF2
resulted in significantly(P ≤ 0.05) fewer G418 resistant
colonies in HeLa ORF2 ER– cells than in HeLa ORF2
cells (Figure 3B). This indicates that increased sensitivity
to transient L1 expression cannot explain the differences
in retrotransposition potential between the two cell
lines. Indeed, cells stably expressing L1 ORF2 were
more resistant to L1 toxicity.
To determine whether cells constitutively expressing
L1 ORF2 were less sensitive to DSBs in general, we
measured the toxicity of ionizing radiation (IR) induced
DSBs on HeLa ORF2 and HeLa ORF2 ER– cells. Signifi-
cantly different sensitivity to IR between these cell lines
was not found in either a proliferation or a colony for-
mation assay (Figure 3C, Additional File 3).
Together, these data suggest that the reduced retro-
transposition rates observed in the long term L1 expres-
sing cells are not due to an impaired growth rate, and
additionally cannot easily be explained by differences in
the viability or general health of the cells. The cells
seem to have adapted to the stable expression of L1
ORF2 by specifically diminishing their sensitivity to L1
ORF2 as a source of DSBs.
Repression of retrotransposition is not through
RNA interference
Because several of the known activities of L1 ORF2p
were repressed by chronic exposure of ORF2p, it was
possible that the ORF2 mRNA was being specifically
targeted by RNA interference (RNAi) for degradation, a
mechanism previously suggested to repress L1 activity
[27-30]. To test this possibility, we drove Alu retrotran-
sposition with three synthetic L1 ORF2s containing
silent mutations that changed their nucleotide sequence
up to 22% but did not modify their amino acid sequence
Figure 2 Constitutive L1 expression results in reduced
retrotransposition potential. (A) Scheme for stable cell line
generation. Wild-type cells were transfected with the desired
expression vector. Selection was applied to assure the presence of
this vector and the resulting cells were expanded under selection
from colonies to a new cell line. (B) Constitutive L1 expression in
HeLa cells results in lowered retrotransposition potential.
Mobilization of a tagged L1 or a tagged Alu element, which confers
neomycin resistance to a cell upon successful retrotransposition as
described previously, was measured in HeLa cells selected to stably
express various L1 proteins. Data are means and SD (error bars) of
at least three independent measurements. Asterisks signify a
significant (Student t-test, P ≤ 0.05) difference from
retrotransposition levels seen in HeLa open reading frame (ORF)2
ER– cells. (C) Constitutive L1 Expression in HCT 116 Cells results in
lowered retrotransposition potential. The mobilization of a tagged
L1 or a tagged Alu element, which confers neomycin resistance to
a cell upon successful retrotransposition as described previously,
was measured in HCT cells selected to express stably either L1 ORF2
or luciferase. T Data are means and SD (error bars) of at least three
independent measurements. Asterisks signify a significant (Student
t-test, P ≤ 0.005) difference from retrotransposition levels seen in
HCT 116 luciferase cells.
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HeLa ORF2 ER– cells and found a similar reduction in
Alu retrotransposition in both, regardless of which syn-
thetic L1 ORF2 was used. These data suggest that the
repressive force that is acting on the L1 ORF2 is not
interrupted by large scale changes in the L1 ORF2
mRNA sequences (Figure 4). An even more convincing
argument that RNAi is not influencing the retrotranspo-
sition rates in these experiments is the fact that the con-
trol cells that express mutant L1 ORF2 make the same
L1 RNA molecule as the L1 expressing cells, with only a
two-base difference. Thus, it is very unlikely that these
two almost identical RNAs would not have a similar
influence in the RNAi process.
Constitutive L1 ORF2 expression results in alterations in
DSB repair kinetics
Because L1 expression generates DNA DSBs that are
required for retrotransposition [16], and chronic expo-
sure to DSBs can induce increased DNA repair kinetics
in cells [1], we wanted to study the effect of constitutive
L1 ORF2p expression on DSB repair kinetics. We mea-
sured DSB repair by detecting 53BP1 foci, an early indi-
cator of DSBs, at three time points after exposure to
either 7.8 mmol/L H2O2 or L1 ORF2 expression. 53BP1
foci returned to background levels significantly(P ≤ 0.05)
more rapidly in HeLa ORF2 cells than in HeLa ORF2
ER– cells after both treatments, indicating that exposure
to constitutive L1 ORF2 expression induces a cellular
adaptation that more rapidly repairs DSBs induced by
exposure to either H2O2 or transient L1 ORF2p expres-
sion (Figure 5).
Discussion
Cells adapt to constitutive expression of LINE-1 by
repressing Alu and L1 retrotransposition
Human cells adapt to chronic expression of functional
L1 elements, specifically the L1 ORF2, in a dose depen-
dent manner. This adaptation includes strong suppres-
sion of the retrotransposition potential of both L1 and
A l ue l e m e n t s( F i g u r e2 ) .T h i si sc o n s i s t e n tw i t ho u r
observation that retrotransposition was inversely propor-
tional to endogenous L1 expression in cell lines with
varying levels of endogenous expression of L1 (Figure
1). It has been found that retrotransposition of human
mobile elements is suppressed by a plethora of mechan-
isms, including DNA methylation, transcription regula-
tion, RNA processing, APOBEC (apolipoprotein B
mRNA editing enzyme, catalytic polypeptide-like) pro-
teins and DNA repair pathways [18,23,31-36]. The
abundance of methods used to silence these elements is
probably necessary because of their high copy number,
but also reflects the importance of effective inhibition in
almost all cell types and developmental situations. This
Figure 3 Toxicity in cells undergoing constitutive L1
expression. (A) Constitutive L1 open reading frame (ORF)2
expression in HeLa Cells results in lower sensitivity to transient L1
expression. To measure the toxicity of L1 expression, a plasmid
expressing a neomycin-resistance cassette was cotransfected with a
vector expressing either L1 ORF2 or full length L1 in HeLa ORF2 or
HeLa ORF2 ER– cells. Colony formation was used as a measure of
toxicity as previously described [21]. The relative number of G418
resistant (G418
r) colonies in the two cell lines was measured in
triplicate for cotransfection of full length L1 and L1 ORF2. (B)
Constitutive L1 ORF2 expression in HeLa Cells does not alter
sensitivity to ionizing radiation. HeLa ORF2 and HeLa ORF2 ER– cells
were exposed to four different doses of ionizing radiation. After
exposure, cells were grown for 3 days and the relative numbers of
viable cells were measured. Data are means and SD (error bars) of
six independent measurements. Asterisks signify a significant
(Student t-test, P ≤ 0.0001) difference from the number of G418
r
colonies seen in HeLa ORF2 cells. (C) Constitutive L1 ORF2
Expression in HeLa cells does not alter cellular proliferation rates.
HeLa ORF2 and HeLa ORF2 ER– cells were seeded, harvested by
trypsinization after 1, 2 or 3 days of growth, and viable cells
counted. Data are means and SD (error bars) of three independent
measurements.
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ity provides a fail safe method of reducing the deleter-
ious effects of L1 ORF2 expression.
Figure 6 outlines how this feedback inhibition would be
beneficial to cell growth. In step A, cells are no longer
properly repressing L1 expression, perhaps because of
the global hypomethylation associated with tumorigen-
esis [37-41]. In step B, the loss of this repression results
in a deleterious increase in L1 expression. In response to
this deleterious expression, cells adapt to constitutive L1
expression by increasing the rate of their repair of DSBs,
thus reducing the toxicity associated with transient L1
expression (step C). Finally, in step D, the cells repress
retrotransposition and minimize the negative effect from
insertional mutagenesis and toxicity from L1-induced
DSBs.
It is possible that, although it minimizes retrotranspo-
sition and direct cellular toxicity, the rapid repair of the
DSBs may lead to error prone repair processes. The cel-
lular response to chronic DSBs is to increase NHEJ
repair of lesions and hence more rapidly mend the
break. Cells exposed to chronic low levels of DSBs
induced by L1 also respond by increasing the rate of
DSB repair, mostly likely also by increasing NHEJ [1].
Whereas homology independent repair would eliminate
the immediate toxic effects of L1 expression, NHEJ is an
error prone process that could lead to in increased
mutation rate in cells.
Mechanism of retrotransposition repression by chronic
L1 expression
Initially we considered that reduction of retrotransposi-
tion might be through an RNAi-like mechanism that
responded to the expression of the L1 RNA. However,
we dismissed this possibility because the chronic expres-
sion of L1 was able to repress Alu retrotransposition,
even when an ORF2 with altered nucleotide sequence
was used to drive the Alu. More importantly, expression
of an inactive L1 ORF2, with only a few point muta-
tions, did not show the same repression (ORF2 ER–).
Because the RNA from the mutant ORF2 should only
differ by two bases from the wild type RNA, it is very
unlikely that it would influence RNAi differentially.
Our data indicate that the most likely mechanism of
repression of retrotransposition in our system is a
response induced by the DNA DSBs caused by the L1
endonuclease. Constitutive expression of the L1 endonu-
clease is analogous to the exposure to chronic DSBs,
which results in more rapid DSB repair [1]. Although
these cells had an altered DNA damage response, they
were not more sensitive to ionizing radiation and did
not have altered growth rates, just as we detected in
Figure 4 Repression of Alu Mobilization is not altered by nucleotide sequence variations in L1 open reading frame (ORF)2.I nH e L a
ORF2 and HeLa ORF2 ER– cells, mobilization of a previously described tagged Alu element [45] driven by three synthetic L1 ORF2s [21], each
varying in their nucleotide but not amino acid sequence, was measured. Data are means and SD (error bars) of three independent
measurements. Asterisks signify a significant (Student t-test, P ≤ 0.005) difference from retrotransposition levels seen in HeLa ORF2 ER– cells.
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notable changes in response to chronic L1 treatment,
other than repression of retrotransposition, was that the
cells had a significantly (P ≤ 0.05) faster repair of DSBs
and greater protection from toxicity associated with
transient ORF2p expression (Figure 5). Thus, we specu-
late that stimulation of DNA repair allows the cell to
clear nascent L1 insertion events before they can com-
plete insertion, much like that demonstrated for the
ERCC1/XPF endonuclease [18]. Similarly, it has been
Figure 5 DSB repair kinetics in cells undergoing constitutive L1 expression. (A) Kinetics of 53BP1 foci formation induced by H2O2.A f t e r
treatment with 7.8 mmol/l H2O2, nuclei of HeLa open reading frame (ORF)2 and HeLa ORF2 ER– cells were stained with Hoechst and 53BP1 foci
are revealed by immunofluorescence. These cells were fixed and stained at three time points (45, 75 and 135 minutes after H2O2 treatment). (B)
Quantification of kinetics of 53BP1 foci formation induced by H2O2 53BP1 foci from (A) were counted. Data are means and SD (error bars) of
independent measurements. Asterisks signify a significant (Student t-test, P ≤ 0.05) difference from 53BP1 foci seen in HeLa ORF2 ER– cells. (C)
Kinetics of 53BP1 foci formation induced by transient L1 ORF2 expression. After transient transfection with a vector expressing L1 ORF2, nuclei of
HeLa ORF2 and HeLa ORF2 ER– cells were stained with Hoechst and 53BP1 foci are revealed by immunofluorescence. These cells were fixed and
stained at three time points (16, 20 and 48 hours after transfection). (D) Kinetics of transient 53BP1 foci formation induced by transient L1 ORF2
expression. 53BP1 foci at 16, 20 and 48 hours after transfection were quantified in three separate experiments. Data are means and SD (error
bars) of three independent measurements. Asterisks signify a statistically significant (Student t-test, P ≤ 0.055) difference from 53BP1 foci levels
seen in HeLa ORF2 ER– cells.
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events by rapidly repairing the L1 generated DSB before
the L1 cDNA can be integrated into the break [42].
We found a significant (P ≤ 0.05) increase in DNA repair
associated with a decrease in retrotransposition. The
change in DSB repair timing was measured by the forma-
tion and clearance of 53BP1 foci. 53BP1 foci format DSBs
and are associated with NHEJ mediated repair of these
lesions [43]. Because of this association, our data imply an
increase in NHEJ repair specifically. Therefore, a likely
mechanism for our observed feedback inhibition of retro-
transposition is that chronic L1 ORF2 expression induces
higher levels of NHEJ that restrict retrotransposition.
We showed that constitutive L1 expression could induce
a cellular adaptation that results in more rapid repair of
DSBs and repression of retrotransposition. Because it has
been suggested that an increase in DSB repair kinetics
would decrease retrotransposition, we propose that these
two adaptations are related. It is likely that cells adapt to
chronic L1 expression by increasing the kinetics of DSB
repair, which inhibits retrotransposition. This work high-
lights the intimate relationship between retrotransposition
and DSB repair. In addition, we demonstrate a novel
method of cellular adaptation utilized to diminish the toxi-
city associated with L1 activity.
Methods
Northern blots
We combined the contents of four 75 cm
2 cell culture
flasks of each cell type and extracted total mRNA
Figure 6 Model of feedback inhibition of retrotransposition. In healthy cells, L1 expression is regulated by several mechanisms, but on
occasion one or more of these mechanisms can be disrupted, such as loss of methylation induced repression of the L1 promoter associated
with early tumorigenesis (A). This loss of regulation of L1 expression is a greatly deleterious condition for cells (B). Cells adapt to constitutive L1
expression by more rapidly repairing double stranded breaks (C). We propose that this increased speed of repair results both in the inhibition of
L1 and Alu retrotransposition, and a reduced sensitivity to transient L1 expression (D). Lightning bolts represent toxicity associated with transient
L1 expression. Their size represents the relative magnitude of this toxicity. Cells appear green to represent the deleterious nature of L1 open
reading frame (ORF)2 expression. Darker shades of green represent cells experiencing greater levels of L1 ORF2-associated toxicity.
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then carried out chloroform extraction and isopropanol
precipitation. We selected poly(A) RNA species using a
commercial kit (PolyATract mRNA Isolation System III;
Promega, Sunnyvale, CA, USA) as instructed by the
manufacturer. We resuspended the poly(A) selections
and precipitated RNA in 30 μl of RNase-free water and
fractionated it in a single lane of agarose formaldehyde
gel.
We transferred RNA to a nylon membrane (Hybond-
N; Amersham Pharmacia Biotech, Piscatawy, NJ, USA)
by capillary transfer overnight at room temperature in a
standard 5× sodium chloride/sodium citrate (SSC) solu-
t i o n .W ec r o s s l i n k e dt h eR N At ot h em e m b r a n ew i t h
ultraviolet light and prehybridized it in 30% formamide,
1x Denhardt’s solution, 1% SDS, 1 mol/l NaCl, 100 μg/
ml salmon sperm DNA and 100 μg/ml yeast tRNA at
60°C for at least 6 hours. Hybridization with a strand
specific probe was carried out overnight in the same
solution at 60°C. We carried out several 10-minute
washes at high stringency (0.1x SSC, 0.1% SDS) at 60°C.
We generated (MAXIscript T7 system; Ambion Inc.
Austin, TX, USA) the strand specific probe used for the
northern blot assay. Primer sequences for generating the
template are available on request.
Retrotransposition assays
Transient L1 [12] or Alu [26] retrotransposition assays
were performed as previously described with some
minor modifications. Briefly, cells were seeded into T-75
flasks at a density of 5 × 10
5 cells per flask. Transient
transfections were performed the next day (Lipofecta-
mine and Plus cocktail; Invitrogen), in accordance with
the manufacturer’s protocol. Cells were grown under
selection media containing 400 μg/ml G418 (Geneticin;
Fisher Scientific, Pittsburgh, PA, USA) for 14 days.
Colonies were fixed, stained and visually scored.
53bp1 foci visualization
Cells were plated onto a 96 well imaging plate 16 hours
before visualization, and treated with 3.7% formaldehyde
followed by 90% cold methanol. After washing, cells
were blocked with 1% bovine serum albumin, before
being incubated with 2 μg/ml of a 53bp1 antibody
(Novus Biologicals, Littleton, CO, USA) for 1 hour.
Cells were incubated with 5 μg/ml Alexa 488 conjugated
secondary antibodies (Molecular Probes, Eugene, OR,
USA) and 5 μg/ml Hoechst stain (Molecular Probes)
before being visualized.
ORF2 western blots
HeLa cells stably integrated with the L1 constructs were
grown to confluence in T75 flasks. Cells were treated
with trypsin and pelleted at 300 g,w a s h e dt w i c ew i t h
phosphate-buffered saline (PBS), and finally resuspended
in 400 uL of PBS. Cells were lysed with an equal volume
of 2× Laemmli buffer and boiled for 5 minutes. Extracts
were fractionated on a 3 to 8% Tris-acetate gel (Invitro-
gen) and transferred to nitrocellulose membranes(iBlot
System; Invitrogen). Membranes were blocked for
1 hour in 5% milk in PBS-Tween and incubated with
a-ORF2 antibody (S19, Santa Cruz Biotechnology) over-
night at 4°C. Detection was carried out using horserad-
ish peroxidase conjugated secondary antibodies (Santa
Cruz Biotechnology) and a substrate kit (SuperSignal
West Femto Maximum Sensitivity Substrate Kit;
Thermo Scientific, Waltham, MA, USA). Membranes
were exposed to BioMax Light Film (Kodak) and devel-
oped with a processor (Kodak X-OMAT 2000A; Roche-
ster, NY, USA). Equal loading was confirmed using
b-actin antibodies (Sigma Chemical Co., St Louis, MO,
USA) using the same protocol.
Growth rate
Growth rate was measured as previously described [44]
with minor alterations. Briefly, cells were seeded into T-
75 flasks at a density of 5 × 10
5 cells per flask. After 1,
2 or 3 days of growth, the cells were collected by trypsi-
nization and quantified using a hemocytometer.
Colony formation assay
Colony formation assays were performed as previously
described [21] with some minor modifications. Briefly,
cells were seeded into T-75 flasks at a density of 5 ×
10
5 cells per flask. Transient transfections of a neomycin
resistance plasmid were performed the next day (Lipo-
fectamine and Plus cocktail; Invitrogen) in accordance
with the manufacturer’s protocol. Cells were grown
under selection media containing 400 μg/ml Geneticin
(Fisher Scientific) for 14 days. Colonies were fixed,
stained and visually scored.
Ionizing radiation colony formation assay
After exposure to ionizing radiation, a colony formation
assay was conducted as described both above and in
previous works [16].
Ionizing radiation cellular proliferation assay
After ionizing radiation exposure, the cell growth assay
described above was conducted, with the minor altera-
tion that cell growth was measured after 7 days instead
of 1 to 3 days.
Vectors and sequences
All expression vectors used to generate stable cell lines
and to drive Alu retrotransposition (including L1 ORF2
A, B and C) were cloned into the pBud CE 4.1 vector by
ligation after digestion with BamHI and HinDIII.
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Page 9 of 11The ORF1 sequence of the L1 optimized for expres-
sion has previously been described [43]. The L1 ORF2
used in this vector has had synonymous codons replaced
with codons of maximum translational efficiency, using
a Codon Adaptation Index calculator (http://www.evol-
vingcode.net) in a manner that preserved the amino acid
sequence of the protein.
Statisical Analysis
In all cases, p-values were determined using the student
t-test to compare values to the control for each
experiment.
Additional material
Additional file 1: Figure 1A. Cells stably expressing L1 ORF2 have an
increased number of endogenous DSBs. (A) Nuclei of untreated HeLa
ORF2 and HeLa ORF2 ER– cells were stained with Hoechst, and 53BP1
foci revealed by immunofluorescence. (B) 53BP1 foci of untreated HeLa
ORF2 and HeLa ORF2 ER– cells were quantified six times. Data are means
and SD (error bars) of these six independent measurements. The two cell
lines were significantly different (P ≤ 0.05). (C) Western blots with an
antibody to the N-terminal portion of ORF2 were carried out on
transiently transfected HeLa cells (M), HeLa cells transformed with the L1
endo./RT double-mutant (lane 1; ORF2 ER- in Figure 2B), HeLa cells
transformed with ORF2 expression vector (lane 2; ORF2 in Figure 2B) or
an optimized L1 vector (lane 3; Opt L1 in Figure 2B) and untransfected
HeLa (lane 4). The ORF2 band is marked, as well as a blot of actin on the
same membrane.
Additional file 2: Figure 2. Repression of Alu retrotransposition is not
influenced by the source of L1 ORF2. The retrotransposition of a tagged
Alu element driven by a vector expressing full length L1 or L1 ORF2 was
measured in HeLa ORF2 and HeLa ORF2 ER– cells. Asterisks signify a
statistically significant (Data are means and SD (error bars) of three
independent measurements. ≤ 5×1 0
-6) difference from 53BP1 foci levels
seen in HeLa ORF2 ER– cells.
Additional file 3: Figure 3. Constitutive expression of L1 ORF2 does not
affect sensitivity to 1 Gy of ionizing radiation. The sensitivity of HeLa
ORF2 and HeLa ORF2 ER– cells to 1 Gy of ionizing radiation was
measured by transfecting the cells with a neomycin resistance vector
after exposure to 1 Gy of ionizing radiation. Data are means and SD
(error bars) of five independent measurements.
Additional file 4: Figure 4A, B. (A) Percentage similarity between
synthetic L1 ORF2s. Similarity between the synthetic L1 ORF2s is listed in
table form. This percentage was calculated as total unchanged
nucleotides divided by total nucleotides. (B) Sequence alignments of
synthetic L1 ORF2s. The row labels refer to the synthetic L1 ORF2
sequence being displayed. (A) signifies L1 ORF2A, (B) signifies L1 ORF2B.
C signifies L1 ORF2C. The L1 ORF2 sequences are aligned with L1 ORF2A.
Nucleotides matching the L1 ORF2A sequence are shaded.
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